Trodelvy 180 MG vials
Ended Awarded
- Contract number
- SPE2DB25FJT89
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,182
Award facts
- Contract value 100% obligated
- $11,182.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials under a firm fixed-price contract valued at $11,182.01, with a completion date of September 25, 2025. This competitive award, issued on September 4, 2025, contains no set-aside designation and will be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. Trodelvy (sacituzumab govitecan) is a targeted cancer therapy used primarily in the treatment of triple-negative breast cancer and other solid tumors, representing a specialized pharmaceutical product within AmerisourceBergen's extensive portfolio of federal medical supplies.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a critical vendor for the Defense Health Agency and other federal healthcare systems, supplying a comprehensive range of medications, vaccines, and medical devices to support military healthcare programs globally. The company's federal contract performance demonstrates consistent capability in fulfilling competitive procurement requirements across multiple therapeutic domains, positioning it as a key supplier within the military's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FJT89?
SPE2DB25FJT89 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FJT89 worth?
The government has obligated $11,182 on SPE2DB25FJT89.
Is contract SPE2DB25FJT89 an order under another contract?
Yes. SPE2DB25FJT89 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJT89 competed?
The extent of competition for SPE2DB25FJT89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award